Showing results (1071-1080 of 1,344) with videos related to
Sort By:
Pageof 135
The Pharmacogenomics Journal|May 26, 2020
Analysis of association of ADORA2A and ADORA3 polymorphisms genotypes/haplotypes with efficacy and toxicity of methotrexate in patients with Rheumatoid arthritisMilka Grk, Vera Milic, Vita Dolzan, et al.The Pharmacogenomics Journal|August 13, 2022
Development of an extensive workflow for comprehensive clinical pharmacogenomic profiling: lessons from a pilot study on 100 whole exome sequencing dataAlireza Tafazoli, Maaike van der Lee, Jesse J Swen, et al.The Pharmacogenomics Journal|November 8, 2022
The organoid as reliable cancer modeling in personalized medicine, does applicable in precision medicine of head and neck squamous cell carcinoma?Alieh Farshbaf, Malihe Lotfi, Reza Zare, et al.The Pharmacogenomics Journal|May 20, 2015
Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01L R Parham, L P Briley, L Li, et al.The Pharmacogenomics Journal|July 8, 2015
Genetic screening reveals a link between Wnt signaling and antitubulin drugsA H Khan, J S Bloom, E Faridmoayer, et al.The Pharmacogenomics Journal|July 8, 2015
Pharmacogenomic variants have larger effect sizes than genetic variants associated with other dichotomous complex traitsJ C Maranville, N J CoxThe Pharmacogenomics Journal|June 7, 2020
Pharmacogenetics of hypoglycemia associated with sulfonylurea therapy in usual clinical careSabrina L Mitchell, Daniel A Carranza Leon, Sandip Chaugai, et al.The Pharmacogenomics Journal|September 4, 2021
Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug testsGuang-Dan Zhu, Penn Whitley, Leah LaRue, et al.The Pharmacogenomics Journal|June 18, 2020
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapyMaja Guberina, Ali Sak, Christoph Pöttgen, et al.The Pharmacogenomics Journal|November 5, 2022
Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorderErik Joas, Lina Jonsson, Alexander Viktorin, et al.Pageof 135